US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silexion Therapeutics Corp

1.11

-0.1400-11.20%

Post-market: 1.120.0100+0.90%19:55 EDT

Volume:597.18K

Turnover:702.86K

Market Cap:9.34M

PE:-0.91

High:1.26

Open:1.23

Low:1.11

Close:1.25

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Silexion Therapeutics Corp

Exchange:

NASDAQ

Establishment Date:

2008

Employees:

- -

Office Location:

The Goldyne Savad Institute of Gene Therapy,Hadassah Hebrew University Medical Center,Jerusalem,Israel

Website:

http://www.silexion.com

Zip Code:

9112001

Phone:

Fax:

972 2 643 0982

Introduction:

Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.

Directors

Name

Position

Ilan Levin

Chairman of the Board, Director, Secretary and Chief Executive Officer

Craig Marshak

Director

Eric Brachfeld

Director

Michael Basch

Director

Ruth Alon

Director

Shareholders

Name

Position

Ilan Levin

Chairman of the Board, Director, Secretary and Chief Executive Officer

Gil Maman

Chief Financial Officer

Dan Yalon

Advisor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SLXN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":1.11,"timestamp":1742414400000,"preClose":1.25,"halted":0,"volume":597177,"hourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.11,"latestTime":"19:55 EDT","volume":42189,"amount":47216.6705,"timestamp":1742428531217},"delay":0,"changeRate":-0.112,"change":-0.14,"floatShares":5231700,"shares":8414615,"eps":-1.215216,"lyrEps":0.386244,"amount":702857.2041350999,"amplitude":0.11848,"volumeRatio":0.280825,"dividePrice":0,"prevYearClose":2.01,"fiveDayClose":1.38,"twentyDayClose":0.9877},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":5231700,"roa":"--","roe":"--","lyrEps":0.386244,"volumeRatio":0.280825,"shares":8414615,"dividePrice":0,"high":1.2581,"amplitude":0.11848,"preClose":1.25,"low":1.11,"week52Low":0.575,"pbRate":"--","week52High":122.0184,"institutionHeld":0,"latestPrice":1.11,"eps":-1.215216,"divideRate":0,"volume":597177,"delay":0,"ttmEps":-1.215216,"open":1.23,"prevYearClose":2.01,"prevWeekClose":1.31,"prevMonthClose":1.07,"prevQuarterClose":2.01,"fiveDayClose":1.38,"twentyDayClose":0.9877,"sixtyDayClose":2.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1730520000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134350646,"yearFounded":2008,"address":"The Goldyne Savad Institute of Gene Therapy,Hadassah Hebrew University Medical Center,Jerusalem,Israel","zipCode":"9112001","officePhone":"972 2 674 3430","officeFax":"972 2 643 0982"},"stockCompanyDetail":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":0.1574},{"period":"3month","weight":-0.4159},{"period":"6month","weight":-0.8264},{"period":"1year","weight":-0.9875},{"period":"ytd","weight":-0.3781}],"compareEarnings":[{"period":"1week","weight":0.0092},{"period":"1month","weight":-0.0798},{"period":"3month","weight":-0.0431},{"period":"6month","weight":-0.0174},{"period":"1year","weight":0.0939},{"period":"ytd","weight":-0.0428}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0087},{"month":2,"riseRate":0.75,"avgChangeRate":-0.104682},{"month":3,"riseRate":1,"avgChangeRate":0.048738},{"month":4,"riseRate":1,"avgChangeRate":0.008863},{"month":5,"riseRate":0.25,"avgChangeRate":-0.001105},{"month":6,"riseRate":0.5,"avgChangeRate":0.01089},{"month":7,"riseRate":1,"avgChangeRate":0.012186},{"month":8,"riseRate":0.5,"avgChangeRate":-0.219676},{"month":9,"riseRate":0.75,"avgChangeRate":-0.154717},{"month":10,"riseRate":0.5,"avgChangeRate":-0.107747},{"month":11,"riseRate":0.5,"avgChangeRate":0.013201},{"month":12,"riseRate":0.25,"avgChangeRate":-0.069674}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":{"directors":[{"name":"Ilan Levin","position":"Chairman of the Board, Director, Secretary and Chief Executive Officer"},{"name":"Craig Marshak","position":"Director"},{"name":"Eric Brachfeld","position":"Director"},{"name":"Michael Basch","position":"Director"},{"name":"Ruth Alon","position":"Director"}],"executives":[{"name":"Ilan Levin","position":"Chairman of the Board, Director, Secretary and Chief Executive Officer"},{"name":"Gil Maman","position":"Chief Financial Officer"},{"name":"Dan Yalon","position":"Advisor"}]}}}